Affordable, quality health care. For everyone.

Annual Drug Review in Switzerland to Save Millions Annually

Country Correspondent: Lars Hemkens

In 2017, the Swiss Federal Office of Public Health (FOPH) reduced prices for more than 400 prescription drugs, resulting in savings of approximately CHF 190 million in 2017 alone. The average price reduction per drug was approximately 18 percent. FOPH conducts a review of all drugs covered under the statutory health insurance system every three years. The review is based on cross-country comparisons and comparisons with other drugs.

Publication Details

Publication Date: August 15, 2018